Genome Engineering Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Our latest research report entitled Genome Engineering Market (by technology (clustered regularly interspaced short palindromic repeats, and other), application (cell line engineering, animal genetic engineering, and other) and end-user (biotechnology & pharmaceutical companies, academic & government research institutes and others)) provides complete and deep insights into the market dynamics and growth of Genome Engineering. Latest information on market risks, industry chain structure Genome Engineering cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential Genome Engineering growth factors.

The forecast Genome Engineering Market information is based on the present market situation, growth opportunities, development factors, and opinion of the industry experts. An in-depth analysis of the company profiles, Genome Engineering on a global and regional level and applications is conducted. The analysis of downstream buyers, sales channel, raw materials, and industry verticals is offered in this report. According to the report the global genome engineering market is projected to grow at a CAGR of 11.80% over the forecast period of 2018-2024.

Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/1327

Genome engineering market was worth XX million in 2017 and is projected to reach XX million by 2024. A genome is the genetic material of an organism. Genome engineering or genome editing is a type of genetic engineering in which DNA is inserted, modified, deleted or replaced in the genome of the living organism. Several approaches to genome editing have been developed. A recent one is known as CRISPR-Cas9, which is short for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9. Genome editing is of huge interest in the prevention and treatment of human diseases. Currently, most research on genome engineering is done to understand diseases using cells and animal models.

Rising prevalence of infectious diseases and cancer and availability of research grants & funding from the government are the primary factors responsible for driving the genome engineering market. Genome engineering is widely used in biotechnology and pharmaceutical companies, these companies are constantly indulged in research and development activities to prepare an antidote for the various infectious disease and cancer that helps to augment market growth. However, lack of trained professionals and adverse public perception of genetic research is likely to be the restraint for the market growth.

The use of genetic engineering to treat increasingly prevalent chronic diseases and in preparing specialized or personalized medicine can create huge growth opportunities in the near future for genome engineering market.

Geographically, North America is in the leading position among the other regions with a significant market share. The U.S drives the North America genome engineering market, on account of factors such as the development of gene therapy, increasing the use of genetically modified crops and huge government funding for genome engineering research. Europe is expected to grow at the highest CAGR during the forecast period, 2018-2024.

Market Segmentation by Technology, Application, and End-User

The report on global genome engineering market covers segments such as technology, application, and end-user. On the basis of technology the global genome engineering market is categorized into clustered regularly interspaced short palindromic repeats (CRISPR), transcription activator-like effector nuclease (TALEN), zinc finger nuclease (ZFN) and other technologies. On the basis of application, the global genome engineering market is categorized into cell line engineering, animal genetic engineering, plant genome engineering, and other applications. On the basis of end-user, the global genome engineering market is categorized into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations.

Ask Discount for the latest research report @ https://www.infiniumglobalresearch.com/reports/request-discount/1327

Competitive Landscape

The report provides profiles of the companies in the global genome engineering market such as Thermo Fisher Scientific, Merck, Horizon Discovery Group, Genscript, Sangamo Biosciences, Integrated DNA Technologies, Lonza, New England Biolabs, Origene Technologies and Transposagen Biopharmaceuticals.

Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-genome-engineering-market

Infinium Global Research and Consulting Solutions is started with a single motto of being a business partner of the first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Infinium Global Research
Office No. 04, 06, Ganadhish Empire,
Rahatani Corner, Pune, MH 411027
Email: info@infiniumglobalresearch.com
Website: www.infiniumglobalresearch.com

This release was published on openPR.